MedTrace Logo

Development of a Screening Strategy for Community-based Adverse Drug Related Events in the Emergency Department

NCT00727610 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1588

Last updated 2011-02-17

No results posted yet for this study

Summary

Adverse Drug Related Events (ADREs) are a leading cause of Emergency Department (ED) visits in Canada. However emergency physicians recognize only half of all ADREs in patients presenting to the ED, missing opportunities to intervene. The objective of this study is to develop a screening strategy that identifies patients with ADREs. Our hypothesis is that the development of a user-friendly, reliable screening strategy for ADREs in patients presenting to the ED is feasible. We believe that this will lead to improved patient care.

Conditions

  • Adverse Drug Related Events

Sponsors & Collaborators

  • Canadian Patient Safety Institute

    collaborator OTHER

  • Michael Smith Foundation for Health Research

    collaborator OTHER

  • Vancouver Coastal Health

    collaborator OTHER_GOV

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Corinne M. Hohl · University of British Columbia

  • Jeffrey R. Brubacher · University of British Columbia

  • Samuel B. Sheps · University of British Columbia

  • Linda Dempster · University of British Columbia

  • Garth Hunt · University of British Columbia

  • Claude Stang · University of British Columbia

  • Janet Joy · University of British Columbia

  • Peter Loewen · University of British Columbia

  • Matthew Wiens · University of British Columbia

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00727610 on ClinicalTrials.gov